jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 16, 2009

Dec. 17, 2018

jRCT2080220769

Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis

version:
date:

DAIICHISANKYO Co.,Ltd.

http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html

Interventional

3

Involutional (postmenopausal and senile) osteoporotic subjects with prevalent fragility vertebral fracture(s)

No limit
No limit

Both

Involutional (postmenopausal and senile) osteoporosis

investigational material(s)
Generic name etc : Denosumab
INN of investigational material :
Therapeutic category code : 399 Agents affecting metabolism, n.e.c.
Dosage and Administration for Investigational material : Subcutaneous injection

DAIICHISANKYO Co.,Ltd.

JapicCTI-090797

History of Changes

No Publication date
12 Dec. 17, 2018 (this page) Changes
11 Feb. 18, 2015 Detail Changes
10 Feb. 18, 2015 Detail Changes
9 Sept. 30, 2014 Detail Changes
8 Sept. 30, 2014 Detail Changes
7 Sept. 30, 2014 Detail Changes
6 Sept. 30, 2014 Detail Changes
5 Mar. 13, 2013 Detail Changes
4 Mar. 13, 2013 Detail Changes
3 Jan. 27, 2011 Detail Changes
2 July. 16, 2009 Detail Changes
1 July. 16, 2009 Detail